RecruitingNCT07059793

MITRIS China Post Market Clinical Follow-up (PMCF) Study

Post-Market Clinical Follow-up Study of Edwards Lifesciences MITRIS RESILIA Mitral Valve in Chinese Population

Sponsor

Edwards Lifesciences

Enrollment

250 participants

Start Date

Jul 8, 2025

Study Type

OBSERVATIONAL

Conditions

Mitral Valve Replacement

Summary

Collect clinical outcomes on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MITRIS RESILIA Mitral Valve for people with mitral valve replacement. The study is currently recruiting participants at 13 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMITRIS RESILIA Mitral Valve

Surgical replacement of native or prosthetic mitral valve.

Locations(13)

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Fuwai Hospital, CAMS & PUMC

Beijing, Beijing Municipality, China

Xiamen Cardiovascular Hospital Xiamen University

Xiamen, Fujian, China

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, China

Wuhan Asia Heart Hospital

Wuhan, Hubei, China

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China

Nanjing First Hospital

Nanjing, Jiangsu, China

The First Affiliated Hospital of XI'an Jiaotong University

Xi'an, Shaanxi, China

Qilu Hospital of Shandong University

Jinan, Shandong, China

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

Ningbo Medical Center Lihuili Hospital

Ningbo, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07059793

Related Trials

Abbott Cephea Mitral Valve Disease Registry

NCT0706967323 locations

Replacement of the Native Mitral Valve Using the ReValve System

NCT076012692 locations